As expected, we also observed tumor‐promoting factors (TGFβ, VEGF, MMP‐2, MMP‐9, and HIF‐1α) were reduced in BDM‐treated groups compared with the control animals (Fig. 5B). The gene discussed is TGFB1; the disease is neoplasm.